title: Immunotherapy of cervical cancer as a biological dissipative structure.
abstract: Cervical cancer can be not only prevented, but also effectively treated. Decreased efficiency of biochemical, neurohormonal and/or immunological mechanisms leads to infectious states which, irrespective of their bacterial, viral or parasitic aetiology, are only the necessary, but not the sufficient causes of neogenesis. The cause of cancer is the natural and common phenomenon of the self-organization of systems, endangered by ending of their existence, into more efficient time-space structures at the expense of their surrounding. Infected cells or infectiously changed tissues in their final phase of existence are often recognized as a precancerous state, but their genome does not differ from other organism cells, and that is why the carcinogenesis can still be prevented by direct fighting of pathogenic microorganisms, and indirectly by strengthening the body by neurohormonal therapy or vaccine immunopotentialization. Primary prophylaxis of neoplasms requires that not only the dissipathogenic state of cells be prevented, but also their tissue surrounding be normalized to head off the risk of the self-organization of neoplastic forms of life, differing in their genetic identity from the surrounding cells. Lactovaginal immunopotentialization complements the conservative and operative methods of oncological treatment, as well as has prophylactic application in women with the history of miscarriages, premature deliveries, lack of or significantly shortened lactation, neurohormonal menstruating disorders, chronic and recurrent inflammations of the reproductive organs, long-term hormonal contraception and hormone replacement therapy during menopause, or only deficiency of Lactobacillus vaginalis, as indicators of risk of cervical cancer.
authors.affiliation: Fertility Centre Cracow, Poland. mmklimek@cyf-kr.edu.pl
authors.forename: Rudolf
authors.initials: R
authors.lastname: Klimek
authors.forename: Marek
authors.initials: M
authors.lastname: Klimek
authors.forename: Dariusz
authors.initials: D
authors.lastname: Jasiczek
mesh_terms: D005260:Female; D006801:Humans; D007107:Immune System / Q000502:physiology*; D007167:Immunotherapy / Q000639:trends*; D007239:Infections / Q000276:immunology*; D011230:Precancerous Conditions / Q000276:immunology / Q000517:prevention & control / Q000628:therapy; D002583:Uterine Cervical Neoplasms / Q000276:immunology / Q000517:prevention & control / Q000628:therapy